ClinicalTrials.govpublic full text
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
solid tumor, fgfr3-targeting adc, antibody-drug conjugate, fgrf3, adc, fgfr3 alteration, advanced cancers, cemiplimab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 991678
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.